Strict regulations have stunted study on cannabidiol, but that hasn’t hampered solution reputation
A couple of months back, a new storefront appeared in my modest Oregon town. Its shelves have been packed with tinctures, jars of salve, coffee beans, bath bombs — even beard oil. This motley collection shared a single star ingredient: CBD.
Made by the cannabis plant, CBD is the straitlaced cousin of marijuana’s extra renowned element — the THC that delivers a thoughts-swirling higher. CBD, or cannabidiol, has no such intoxicating effects on the thoughts. But the molecule has captured people’s interest in a profound way, sold as a remedy for discomfort, anxiousness, insomnia and other ailments — all without having the higher.
That neighborhood shop, CBD Scientific, is far from alone in its efforts to sell persons on the added benefits of CBD, which is located in each marijuana and hemp, two versions of the Cannabis sativa plant. CBD is popping up in goods in pet retailers, coffee shops and the overall health and beauty sections of mainstream grocery retailers. It is even becoming brewed into beer. I left the shop with a $five bottle of water infused with “5,000,000 nanograms” of CBD.
So far, messages of CBD’s purported overall health added benefits come from persons attempting to sell CBD goods — not from scientists, says Margaret Haney, a neurobiologist who directs the Marijuana Investigation Laboratory at Columbia University. A gaping chasm separates the surging CBD industry and the scientific proof backing it. [Read More @ Science News]